ArticleEquine veterinary journal2026
Calcitonin gene-related peptide concentration in cerebrospinal fluid and serum in horses affected by trigeminal-mediated headshaking.
Article in Equine veterinary journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTrigeminal-mediated headshaking (TMHS) in horses shares clinical features with human trigeminal neuralgia (HTN). Increased levels of the neuropeptide calcitonin gene-related peptide (CGRP) have been found in the blood and cerebrospinal fluid (CSF) of HTN patients. Inhibition of CGRP in humans has shown promise for pain relief. Data on CGRP in horses affected by TMHS are currently lacking but if quantifiable and validated, could assist in developing new diagnostic and more rational therapeutic approaches.
objectivesThis study aimed to quantify and correlate CGRP concentrations in the serum and CSF of horses with TMHS; compare CSF CGRP levels across horses with various neurological, painful, inflammatory and chronic conditions; analyse serum CGRP concentrations before and after exercise-induced headshaking in affected horses versus healthy controls. STUDY
designCase-control study using bio-banked samples and prospective before-after study.
methodsCGRP concentrations were measured in CSF and serum using a commercial ELISA kit across healthy controls (CONTROL, n = 5), TMHS-affected horses (n = 30), horses with cervical vertebral stenotic myelopathy (CVSM, n = 10) and horses with non-neurologic painful, inflammatory or chronic conditions (MIXED, n = 8).
resultsMedian (interquartile range [IQR]) serum CGRP concentration in TMHS horses was 14.9 pg/mL (11.3-19.0 pg/mL), while mean ± SD CGRP CSF concentration was 64.9 ± 6.3 pg/mL. No correlation was found between serum and CSF CGRP (Spearman's rho = -0.04, p = 0.88). CSF CGRP levels were significantly higher in CVSM (73.8 pg/mL; p = 0.011) and lower in MIXED (52.0 pg/mL; p = 0.001) compared to TMHS. Serum CGRP concentrations showed no significant difference between TMHS and CONTROL groups. MAIN LIMITATIONS: Small sample size, lack of CSF samples from healthy controls.
conclusionsHigher CSF CGRP levels in neurologic conditions may suggest shared underlying mechanisms such as nerve irritation or neuroinflammation. Further research is needed to elucidate CGRP's role in TMHS pathophysiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.